BlackRock’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-38,735
Closed -$27.1K 5364
2023
Q4
$27.1K Sell
38,735
-795
-2% -$557 ﹤0.01% 4972
2023
Q3
$27.2K Hold
39,530
﹤0.01% 5031
2023
Q2
$95.3K Buy
39,530
+2
+0% +$5 ﹤0.01% 4844
2023
Q1
$321K Sell
39,528
-12
-0% -$97 ﹤0.01% 4571
2022
Q4
$469K Sell
39,540
-16
-0% -$190 ﹤0.01% 4536
2022
Q3
$549K Sell
39,556
-259
-0.7% -$3.6K ﹤0.01% 4609
2022
Q2
$1.4M Buy
39,815
+73
+0.2% +$2.56K ﹤0.01% 4306
2022
Q1
$1.59M Buy
39,742
+387
+1% +$15.5K ﹤0.01% 4402
2021
Q4
$1.67M Buy
39,355
+149
+0.4% +$6.31K ﹤0.01% 4412
2021
Q3
$2.66M Buy
39,206
+27
+0.1% +$1.83K ﹤0.01% 4138
2021
Q2
$3.02M Buy
39,179
+12,203
+45% +$939K ﹤0.01% 4026
2021
Q1
$1.78M Buy
26,976
+7,925
+42% +$521K ﹤0.01% 4256
2020
Q4
$647K Buy
19,051
+4
+0% +$136 ﹤0.01% 4227
2020
Q3
$1.04M Hold
19,047
﹤0.01% 4003
2020
Q2
$716K Sell
19,047
-2,121
-10% -$79.7K ﹤0.01% 4048
2020
Q1
$530K Buy
21,168
+290
+1% +$7.26K ﹤0.01% 3967
2019
Q4
$1.02M Buy
20,878
+7,221
+53% +$354K ﹤0.01% 3932
2019
Q3
$674K Sell
13,657
-96
-0.7% -$4.74K ﹤0.01% 4045
2019
Q2
$1.25M Buy
13,753
+205
+2% +$18.7K ﹤0.01% 3891
2019
Q1
$2M Sell
13,548
-221
-2% -$32.6K ﹤0.01% 3664
2018
Q4
$2.17M Buy
13,769
+1,063
+8% +$167K ﹤0.01% 3606
2018
Q3
$3.11M Buy
12,706
+8,516
+203% +$2.09M ﹤0.01% 3586
2018
Q2
$939K Buy
4,190
+298
+8% +$66.8K ﹤0.01% 3882
2018
Q1
$954K Sell
3,892
-68
-2% -$16.7K ﹤0.01% 3845
2017
Q4
$1.22M Buy
3,960
+99
+3% +$30.5K ﹤0.01% 3787
2017
Q3
$1.41M Sell
3,861
-45
-1% -$16.5K ﹤0.01% 3734
2017
Q2
$1.42M Buy
3,906
+1,066
+38% +$388K ﹤0.01% 3715
2017
Q1
$844K Buy
+2,840
New +$844K ﹤0.01% 3803